BIOVECTRA Launches Single-use Biologics Fermentation Suite

BIOVECTRA, a global CDMO, is now accepting projects at its manufacturing facility in Windsor, Nova Scotia, Canada, for its new, single-use biologics fermentation suite which contains 100 L and 1,000 L single-use fermenters. BIOVECTRA is the first Canadian CDMO to offer single-use, microbial fermentation at the 1,000 L scale. 
 
The new suite enables execution of a state-of-the-art process train that enhances BIOVECTRA’s microbial fermentation capacity and supports the tech-transfer, optimization, early/mid-stage clinical investigation, and commercial-scale supply of highly specialized therapeutics and biologics.  
 
According to the compnay, the new suite allows for greater flexibility, faster turnaround times, and increased capacity utilization. In particular, companies would no longer be faced with an either/or choice of single-use versus stainless-steel fermenters. The combination of the two can be used for those engaged in clinical-to-commercial scale production. 
 
Additional benefits include a decreased risk of contamination and the elimination of costly, time-consuming cleaning and sterilization between batches, which is essential with stainless-steel equipment.